{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:10:44Z","timestamp":1762452644698,"version":"build-2065373602"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00601-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:15:15Z","timestamp":1746749715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Theoretical investigation of AKT1 mutations in breast cancer: a computational approach to structural and functional insights"],"prefix":"10.1007","volume":"39","author":[{"given":"Balu","family":"Kamaraj","sequence":"first","affiliation":[]},{"given":"George Priya Doss","family":"C","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"601_CR1","doi-asserted-by":"crossref","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q, Liu X, Duan H, Feng Z, Liu Y, Zhang Y (2025) Global burden of female breast cancer: new estimates in 2022, Temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent. Feb 13","DOI":"10.1016\/j.jncc.2025.02.002"},{"issue":"3","key":"601_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"issue":"10440","key":"601_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"SE Vollset","year":"2024","unstructured":"Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbastabar H, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A, Abdelmasseh M (2024) Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021. Lancet 403(10440):2204\u20132256","journal-title":"Lancet"},{"key":"601_CR4","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO, Ram\u00edrez-Valdespino CA (2022) Subtypes of breast cancer. Breast Cancer [Internet]","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"issue":"4","key":"601_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/cancers15041320","volume":"15","author":"B Kinnel","year":"2023","unstructured":"Kinnel B, Singh SK, Oprea-Ilies G, Singh R (2023) Targeted therapy and mechanisms of drug resistance in breast cancer. Cancers 15(4):1320","journal-title":"Cancers"},{"issue":"7","key":"601_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489\u2013501","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"601_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB signaling: navigating the network. Cell 169(3):381\u2013405","journal-title":"Cell"},{"issue":"5029","key":"601_CR8","first-page":"274","volume":"254","author":"A Bellacosa","year":"1991","unstructured":"Bellacosa A, Testa JR, Staal SP, Tsichlis PN (1991) A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254(5029):274\u2013277","journal-title":"Science"},{"issue":"7152","key":"601_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448(7152):439\u2013444","journal-title":"Nature"},{"issue":"8","key":"601_CR10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/sj.bjc.6604637","volume":"99","author":"MA Davies","year":"2008","unstructured":"Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG et al (2008) A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265\u20131268","journal-title":"Br J Cancer"},{"issue":"15","key":"601_CR11","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","volume":"68","author":"K Stemke-Hale","year":"2008","unstructured":"Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M et al (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68(15):6084\u20136091","journal-title":"Cancer Res"},{"issue":"16","key":"601_CR12","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","volume":"8","author":"E Gonzalez","year":"2009","unstructured":"Gonzalez E, McGraw TE (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8(16):2502\u20132508","journal-title":"Cell Cycle"},{"issue":"7","key":"601_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1073\/pnas.0712169105","volume":"105","author":"L Zhao","year":"2008","unstructured":"Zhao L, Vogt PK (2008) Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci U S A 105(7):2652\u20132657","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"601_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee MH (2019) AKT as a therapeutic target for Cancer. Cancer Res 79(6):1019\u20131031","journal-title":"Cancer Res"},{"issue":"14","key":"601_CR15","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0960-9822(02)00972-7","volume":"12","author":"CC Thomas","year":"2002","unstructured":"Thomas CC, Deak M, Alessi DR, van Aalten DMF (2002) High-resolution structure of the pleckstrin homology domain of protein kinase B\/akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr Biol 12(14):1256\u20131262","journal-title":"Curr Biol"},{"issue":"7","key":"601_CR16","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","volume":"9","author":"H Hirai","year":"2010","unstructured":"Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K et al (2010) MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 9(7):1956\u20131967","journal-title":"Mol Cancer Ther"},{"issue":"22","key":"601_CR17","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1158\/1078-0432.CCR-14-0868","volume":"20","author":"TA Yap","year":"2014","unstructured":"Yap TA, Yan L, Patnaik A, Tunariu N, Biondo A, Fearen I et al (2014) Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers. Clin Cancer Res 20(22):5672\u20135685","journal-title":"Clin Cancer Res"},{"issue":"46","key":"601_CR18","doi-asserted-by":"publisher","first-page":"19503","DOI":"10.1073\/pnas.0905056106","volume":"106","author":"AC Faber","year":"2009","unstructured":"Faber AC, Li D, Song Y, Liang MC, Yeap BY, Bronson RT et al (2009) Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K Inhibition. Proc Natl Acad Sci U S A 106(46):19503\u201319508","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"601_CR19","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1073\/pnas.1018001108","volume":"109","author":"A hakrabarty","year":"2012","unstructured":"hakrabarty A, S\u00e1nchez V, Kuba MG, Rinehart C, Arteaga CL (2012) Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proc Natl Acad Sci U S A 109(8):2718\u20132723","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"601_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","volume":"19","author":"S Chandarlapaty","year":"2011","unstructured":"Chandarlapaty S, Sawai A, Scaltriti M, Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V et al (2011) AKT Inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer Cell 19(1):58\u201371","journal-title":"Cancer Cell"},{"issue":"3","key":"601_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","volume":"1","author":"VS Rodrik-Outmezguine","year":"2011","unstructured":"Rodrik-Outmezguine VS, Chandarlapaty S, Pagano NC, Poulikakos PI, Scaltriti M, Moskatel E et al (2011) mTOR kinase Inhibition causes feedback-dependent biphasic regulation of AKT signaling. Cancer Discov 1(3):248\u2013259","journal-title":"Cancer Discov"},{"issue":"5","key":"601_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29(5):625\u2013634","journal-title":"Oncogene"},{"issue":"5","key":"601_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"4","key":"601_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","volume":"9","author":"AB Hanker","year":"2019","unstructured":"Hanker AB, Kaklamani V, Arteaga CL (2019) Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors. Cancer Discov 9(4):482\u2013491","journal-title":"Cancer Discov"},{"issue":"5","key":"601_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1634\/theoncologist.2017-0423","volume":"23","author":"AM Brufsky","year":"2018","unstructured":"Brufsky AM, Dickler MN (2018) Estrogen Receptor-Positive breast cancer: exploiting signaling pathways implicated in endocrine resistance. Oncologist 23(5):528\u2013539","journal-title":"Oncologist"},{"issue":"1","key":"601_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40203-024-00301-5","volume":"13","author":"A Mehmood","year":"2025","unstructured":"Mehmood A, Li R, Kaushik AC, Wei DQ (2025) Comparative analysis of the genomic and expression profiles of ANLN and KDR as prognostic markers in breast Cancer. Silico Pharmacol 13(1):1\u20136","journal-title":"Silico Pharmacol"},{"issue":"2","key":"601_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.jcim.0c00488","volume":"61","author":"A Mehmood","year":"2021","unstructured":"Mehmood A, Kaushik AC, Wang Q, Li CD, Wei DQ (2021) Bringing structural implications and deep learning-based drug identification for KRAS mutants. J Chem Inf Model 61(2):571\u2013586","journal-title":"J Chem Inf Model"},{"issue":"4","key":"601_CR28","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1021\/acsomega.2c04871","volume":"8","author":"A Mehmood","year":"2023","unstructured":"Mehmood A, Nawab S, Jin Y, Kaushik AC, Wei DQ (2023) Mutational impacts on the N and C terminal domains of the MUC5B protein: A transcriptomics and structural biology study. ACS Omega 8(4):3726\u20133735","journal-title":"ACS Omega"},{"issue":"12","key":"601_CR29","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1021\/acsmedchemlett.4c00385","volume":"15","author":"A Mehmood","year":"2024","unstructured":"Mehmood A, Li D, Li J, Kaushik AC, Wei DQ (2024) Supervised screening of EGFR inhibitors validated through computational structural biology approaches. ACS Med Chem Lett 15(12):2190\u20132200","journal-title":"ACS Med Chem Lett"},{"key":"601_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2067-0_1","volume":"2443","author":"EW Sayers","year":"2022","unstructured":"Sayers EW, O\u2019Sullivan C, Karsch-Mizrachi I (2022) Using GenBank and SRA. Methods Mol Biol 2443:1\u201325","journal-title":"Methods Mol Biol"},{"issue":"9","key":"601_CR31","doi-asserted-by":"publisher","first-page":"e12913","DOI":"10.1371\/journal.pone.0012913","volume":"5","author":"WI Wu","year":"2010","unstructured":"Wu WI, Voegtli WC, Sturgis HL, Dizon FP, Vigers GPA, Brandhuber BJ (2010) Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase Inhibition. PLoS ONE 5(9):e12913","journal-title":"PLoS ONE"},{"issue":"1","key":"601_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"601_CR33","unstructured":"Schr\u00f6dinger L 23, DeLano W (2020) PyMOL. Retrieved from http:\/\/www.pymol.org\/pymol"},{"issue":"9","key":"601_CR34","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/bioinformatics\/btac137","volume":"38","author":"Y Jung","year":"2022","unstructured":"Jung Y, Han D, BWA-MEME: (2022) BWA-MEM emulated with a machine learning approach. Bioinformatics 38(9):2404\u20132413","journal-title":"Bioinformatics"},{"issue":"2","key":"601_CR35","doi-asserted-by":"publisher","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO et al (2021) Twelve years of samtools and BCFtools. Gigascience 10(2):giab008","journal-title":"Gigascience"},{"issue":"8","key":"601_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, K\u00e4llberg M et al (2018) Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods 15(8):591\u2013594","journal-title":"Nat Methods"},{"issue":"10","key":"601_CR37","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/genes12101558","volume":"12","author":"NMP Liu","year":"2021","unstructured":"Liu NMP, Dillard H, Ibeawuchi C, Alsaeedy H, Chan T (2021) Improved SNV discovery in Barcode-Stratified scRNA-seq alignments. Genes (Basel) 12(10):1558","journal-title":"Genes (Basel)"},{"key":"601_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-0716-2293-3_19","volume":"2493","author":"P Cingolani","year":"2022","unstructured":"Cingolani P (2022) Variant annotation and functional prediction: SnpEff. Methods Mol Biol 2493:289\u2013314","journal-title":"Methods Mol Biol"},{"key":"601_CR39","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","volume":"7","author":"SW Wingett","year":"2018","unstructured":"Wingett SW, Andrews S (2018) FastQ screen: A tool for multi-genome mapping and quality control. F1000Res 7:1338","journal-title":"F1000Res"},{"issue":"15","key":"601_CR40","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA et al (2011) The variant call format and vcftools. Bioinformatics 27(15):2156\u20132158","journal-title":"Bioinformatics"},{"issue":"19","key":"601_CR41","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M (2016) MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32(19):3047\u20133048","journal-title":"Bioinformatics"},{"issue":"2","key":"601_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"key":"601_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33","journal-title":"J Cheminform"},{"issue":"9","key":"601_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17460441.2016.1216967","volume":"11","author":"S Kim","year":"2016","unstructured":"Kim S (2016) Getting the most out of pubchem for virtual screening. Expert Opin Drug Discov 11(9):843\u2013855","journal-title":"Expert Opin Drug Discov"},{"key":"601_CR45","unstructured":"Abraham MJ, Van Der Spoel D, Lindahl E, Hess B (2014) GROMACS user manual version 5.0. 4. The GROMACS Development Team at the Royal Instituta of Technology and Uppsala University, Sweden"},{"issue":"14","key":"601_CR46","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.3390\/ijms22147602","volume":"22","author":"AM Al-Subaie","year":"2021","unstructured":"Al-Subaie AM, Kamaraj B (2021) The structural effect of FLT3 mutations at 835th position and their interaction with acute myeloid leukemia inhibitors: in Silico approach. Int J Mol Sci 22(14):7602","journal-title":"Int J Mol Sci"},{"key":"601_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12013-013-9697-2","volume":"68","author":"B Kamaraj","year":"2014","unstructured":"Kamaraj B, Purohit R (2014) Computational screening of disease-associated mutations in OCA2 gene. Cell Biochem Biophys 68:97\u2013109","journal-title":"Cell Biochem Biophys"},{"issue":"14","key":"601_CR48","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1080\/07391102.2020.1784790","volume":"39","author":"B Kamaraj","year":"2021","unstructured":"Kamaraj B, Al-Subaie AM, Ahmad F, Surapaneni KM, Alsamman K (2021) Effect of novel leukemia mutations (K75E & E222K) on interferon regulatory factor 1 and its interaction with DNA: insights from molecular dynamics simulations and Docking studies. J Biomol Struct Dynamics 39(14):5235\u20135247","journal-title":"J Biomol Struct Dynamics"},{"issue":"2","key":"601_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/a-1640-0009","volume":"72","author":"S Ram Kumar Pandian","year":"2022","unstructured":"Ram Kumar Pandian S, Kunjiappan S, Pavadai P, Sundarapandian V, Chandramohan V, Sundar K (2022) Delivery of ursolic acid by polyhydroxybutyrate nanoparticles for Cancer therapy: in Silico and in vitro studies. Drug Res (Stuttg) 72(2):72\u201381","journal-title":"Drug Res (Stuttg)"},{"issue":"12","key":"601_CR50","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1021\/ct200196m","volume":"7","author":"AK Malde","year":"2011","unstructured":"Malde AK, Zuo L, Breeze M, Stroet M, Poger D, Nair PC et al (2011) An automated force field topology builder (ATB) and repository: version 1.0. J Chem Theory Comput 7(12):4026\u20134037","journal-title":"J Chem Theory Comput"},{"issue":"13","key":"601_CR51","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1080\/07391102.2019.1667265","volume":"38","author":"BS Gangadharappa","year":"2020","unstructured":"Gangadharappa BS, Sharath R, Revanasiddappa PD, Chandramohan V, Balasubramaniam M, Vardhineni TP (2020) Structural insights of metallo-beta-lactamase revealed an effective way of Inhibition of enzyme by natural inhibitors. J Biomol Struct Dyn 38(13):3757\u20133771","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"601_CR52","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Open Source Drug Discovery Consortium, Lynn A (2014) g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54(7):1951\u20131962","journal-title":"J Chem Inf Model"},{"issue":"5","key":"601_CR53","first-page":"19","volume":"2","author":"PJ Turner","year":"2005","unstructured":"Turner PJ (2005) XMGRACE, version 5.1. Cent Coastal land-margin Res or Graduate Inst Sci Technol Beaverton OR 2(5):19\u201319","journal-title":"Cent Coastal land-margin Res or Graduate Inst Sci Technol Beaverton OR"},{"issue":"8","key":"601_CR54","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/acs.jcim.8b00261","volume":"58","author":"PC Do","year":"2018","unstructured":"Do PC, Lee EH, Le L (2018) Steered molecular dynamics simulation in rational drug design. J Chem Inf Model 58(8):1473\u20131482","journal-title":"J Chem Inf Model"},{"issue":"6","key":"601_CR55","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.3390\/molecules28062731","volume":"28","author":"R Tomarchio","year":"2023","unstructured":"Tomarchio R, Patamia V, Zagni C, Crocetti L, Cilibrizzi A, Floresta G et al (2023) Steered molecular dynamics simulations study on FABP4 inhibitors. Molecules 28(6):2731","journal-title":"Molecules"},{"issue":"14","key":"601_CR56","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1080\/07391102.2017.1401002","volume":"36","author":"X Hu","year":"2018","unstructured":"Hu X, Hu S, Wang J, Dong Y, Zhang L, Dong Y (2018) Steered molecular dynamics for studying ligand unbinding of ecdysone receptor. J Biomol Struct Dyn 36(14):3819\u20133828","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"601_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2019.1580616","volume":"38","author":"Z Yu","year":"2020","unstructured":"Yu Z, Liu Y, Zhu J, Han J, Tian X, Han W et al (2020) Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1\u03b1 and p300. J Biomol Struct Dyn 38(1):1\u201312","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"601_CR58","first-page":"4241","volume":"7","author":"HY Kyung","year":"2015","unstructured":"Kyung HY, Lauring J (2015) Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity. Oncotarget 7(4):4241","journal-title":"Oncotarget"},{"key":"601_CR59","first-page":"260","volume":"10","author":"I Khan","year":"2017","unstructured":"Khan I, Ansari IA (2017) Prediction of a highly deleterious mutation E17K in AKT-1 gene: an in Silico approach. Biochem Biophys Rep 10:260\u2013266","journal-title":"Biochem Biophys Rep"},{"issue":"7","key":"601_CR60","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/life13071532","volume":"13","author":"R Zhang","year":"2023","unstructured":"Zhang R, Akhtar N, Wani AK, Raza K, Kaushik V (2023) Discovering deleterious single nucleotide polymorphisms of human AKT1 oncogene: an in Silico study. Life 13(7):1532","journal-title":"Life"},{"issue":"6","key":"601_CR61","doi-asserted-by":"publisher","first-page":"R687","DOI":"10.1152\/ajpregu.00295.2017","volume":"313","author":"P Rotwein","year":"2017","unstructured":"Rotwein P (2017) Variation in Akt protein kinases in human populations. Am J Physiology-Regulatory Integr Comp Physiol 313(6):R687\u2013R692","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"Pt 2","key":"601_CR62","doi-asserted-by":"publisher","first-page":"124853","DOI":"10.1016\/j.ijbiomac.2023.124853","volume":"242","author":"MR Amiran","year":"2023","unstructured":"Amiran MR, Taghdir M, Abasi Joozdani F (2023) Molecular insights into the behavior of the allosteric and ATP-competitive inhibitors in interaction with AKT1 protein: A molecular dynamics study. Int J Biol Macromol 242(Pt 2):124853","journal-title":"Int J Biol Macromol"},{"key":"601_CR63","doi-asserted-by":"publisher","first-page":"9965906","DOI":"10.1155\/2021\/9965906","volume":"2021","author":"J Ye","year":"2021","unstructured":"Ye J, Li L, Hu Z (2021) Exploring the molecular mechanism of action of Yinchen Wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation. Biomed Res Int 2021:9965906","journal-title":"Biomed Res Int"},{"issue":"14","key":"601_CR64","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/jcmm.17787","volume":"27","author":"W Luo","year":"2023","unstructured":"Luo W, Deng J, He J, Yin L, You R, Zhang L et al (2023) Integration of molecular docking, molecular dynamics and network Pharmacology to explore the multi-target Pharmacology of Fenugreek against diabetes. J Cell Mol Med 27(14):1959\u20131974","journal-title":"J Cell Mol Med"},{"key":"601_CR65","doi-asserted-by":"crossref","unstructured":"Nayana P, Gollapalli P, Manjunatha H (2024) Investigating the structural basis of Piperine targeting AKT1 against prostate cancer through in vitro and molecular dynamics simulations. J Biomol Struct Dyn.;1\u201315","DOI":"10.1080\/07391102.2024.2331096"},{"issue":"1","key":"601_CR66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12906-024-04415-3","volume":"24","author":"L Ralte","year":"2024","unstructured":"Ralte L, Sailo H, Kumar R, Khiangte L, Kumar NS, Singh YT (2024) Identification of novel AKT1 inhibitors from sapria Himalayana bioactive compounds using structure-based virtual screening and molecular dynamics simulations. BMC Complement Med Ther 24(1):116","journal-title":"BMC Complement Med Ther"},{"issue":"2","key":"601_CR67","doi-asserted-by":"publisher","first-page":"107961","DOI":"10.1016\/j.jsb.2023.107961","volume":"215","author":"MG Francia","year":"2023","unstructured":"Francia MG, Oses C, Roberti SL, Garc\u00eda MR, Cozza LH, Diaz MC et al (2023) Sumoylation and the oncogenic E17K mutation affect AKT1 subcellular distribution and impact on Nanog-binding dynamics to chromatin in embryonic stem cells. J Struct Biol 215(2):107961","journal-title":"J Struct Biol"},{"issue":"5","key":"601_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00894-023-05520-9","volume":"29","author":"MR Amiran","year":"2023","unstructured":"Amiran MR, Taghdir M, Abasi Joozdani F (2023) Investigation of the inhibitory behavior of XFE and Mitoxantrone molecules in interaction with AKT1 protein: a molecular dynamics simulation study. J Mol Model 29(5):153","journal-title":"J Mol Model"},{"key":"601_CR69","doi-asserted-by":"publisher","first-page":"105660","DOI":"10.1016\/j.cmpb.2020.105660","volume":"195","author":"K Al-Khafaji","year":"2020","unstructured":"Al-Khafaji K, Taskin Tok T (2020) Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis. Comput Methods Programs Biomed 195:105660","journal-title":"Comput Methods Programs Biomed"},{"key":"601_CR70","doi-asserted-by":"publisher","first-page":"1193132","DOI":"10.3389\/fmed.2023.1193132","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang X, Wang T, Tang Y, Shao Y, Gao Y, Wu P (2023) Treatment of liver fibrosis in hepatolenticular degeneration with traditional Chinese medicine: systematic review of meta-analysis, network Pharmacology and molecular dynamics simulation. Front Med (Lausanne) 10:1193132","journal-title":"Front Med (Lausanne)"},{"key":"601_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pharmthera.2016.12.001","volume":"172","author":"JS Brown","year":"2017","unstructured":"Brown JS, Banerji U (2017) Maximising the potential of AKT inhibitors as anti-cancer treatments. Pharmacol Ther 172:101\u2013115","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00601-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:02:40Z","timestamp":1762452160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00601-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00601-8","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}